Author:
van Giezen J.J.J.,Reitsma J.H.,Bouma B.N.,Hasselaar P.,Reinders J.H.,Jansen J.W.C.M.
Reference49 articles.
1. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue-type plasminogen activator (t-PA) activity and inhibits venous thrombosis;Van Giezen;Thromb Haemost,1992
2. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo;Quax;J Biol Chem,1990
3. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo;Kooistra;Thromb Haemost,1991
4. Inhibition of fibrinolytic activity in-vivo by dexamethasone is counterbalanced by an inhibition of platelet aggregation;Van Giezen;Thromb Haemost,1993
5. High-altitude pulmonary oedema;Singh;Z Kreisl-Forsch,1967